Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

The New England Journal of Medicine

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

The New England Journal of Medicine

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer

The New England Journal of Medicine

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses

Journal of Clinical Oncology

Randomized controlled trial of S-1 versus docetaxelin patients with non-small-cell lung cancer previouslytreated with platinum-based chemotherapy(East Asia S-1 Trial in Lung Cancer)

Annals of Oncology

Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria

Annals of Oncology